Nubeqa

Pharma

Biosimilar competiton takes big bite out of Bayer's Eylea sales

Bayer is getting hit with full force by biosimilar competition for its eye disease treatment Eylea, which saw a 24% sales decline in the first quarter.

Kevin Dunleavy May 12, 2026 10:51am

Bayer earns FDA untitled letter for Nubeqa ad’s risk information

Apr 30, 2026 5:25am

Bayer's pharma division sees one more year of declining sales

Mar 4, 2026 11:35am

Bayer sues J&J over 'deeply flawed' Erleada promotional claims

Feb 23, 2026 1:03pm

Bayer Highlights Real campaign Tony Romo

Bayer has Tony Romo calling plays in Nubeqa drive

Jan 29, 2026 10:40am

Bayer stays positive on newer meds as pharma sales stagnate

Nov 12, 2025 11:46am